Literature DB >> 1409354

Structural modification study of anthracyclinones: synthesis and biological activity of several derivatives of eta-pyrromycinone.

D F Liu1, H Xiong, C C Cheng.   

Abstract

On the basis of the N-O-O triangular pharmacophore hypothesis postulated earlier in our laboratory, selected side chains with or without the nitrogen atom at the strategic position were incorporated to eta-pyrromycinone, one of the anthracyclinones derived from the antibiotic cinerubins. Since none of the anthracyclinones (the aglycones of anthracyclines) were reported to have antineoplastic activity, the validity of the proposed hypothesis could be tested. Results indicated that a compound designed in this manner, 1,4-bis[2-(2,2-dimethyloxazolidin-3-yl)ethylamino]-1,4-didehydr oxy-eta- pyrromycinone (9c) possessed both in vitro and in vivo antineoplastic activity comparable to that of mitoxantrone. The structure-activity relationship of this class of compounds is discussed.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1409354     DOI: 10.1023/a:1015891102895

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  10 in total

1.  Letter: Daunomycin (NSC-82151) and adriamycin (NSC-123127): a hypothesis concerning antitumor activity and cardiotoxicity.

Authors:  R H Adamson
Journal:  Cancer Chemother Rep       Date:  1974 May-Jun

2.  Common receptor-complement feature among some antileukemic compounds.

Authors:  K Y Zee-Cheng; C C Cheng
Journal:  J Pharm Sci       Date:  1970-11       Impact factor: 3.534

3.  [On the identification of a series of anthracycline pigments from Streptomyces galilaeus Stamm JA 3043 (galirubine and galirubinone)].

Authors:  K Eckardt
Journal:  Chem Ber       Date:  1967

4.  Activity of anthracyclines against an adriamycin (NSC-123127)-resistant subline of P388 leukemia with special emphasis on cinerubin A (NSC-18334).

Authors:  R K Johnson; A A Ovejera; A Goldin
Journal:  Cancer Treat Rep       Date:  1976-01

Review 5.  The design, synthesis and development of a new class of potent antineoplastic anthraquinones.

Authors:  C C Cheng; R K Zee-Cheng
Journal:  Prog Med Chem       Date:  1983

6.  Cellular pharmacology of 7(R)-O-methylnogarol: a new anticancer agent.

Authors:  M J Egorin; R E Clawson; J L Cohen; L A Ross; N R Bachur
Journal:  J Pharmacol Exp Ther       Date:  1979-08       Impact factor: 4.030

7.  Antineoplastic agents. Structure-activity relationship study of bis(substituted aminoalkylamino)anthraquinones.

Authors:  R K Zee-Cheng; C C Cheng
Journal:  J Med Chem       Date:  1978-03       Impact factor: 7.446

8.  Structure--activity relationships of nogalamycin analogues.

Authors:  P F Wiley; D W Elrod; D J Houser; F A Richard
Journal:  J Med Chem       Date:  1982-05       Impact factor: 7.446

9.  Physicochemical properties of complexes between deoxyribonucleic acid and antibiotics which affect ribonucleic acid synthesis (actinomycin, daunomycin, cinerubin, nogalamycin, chormomycin, mithramycin, and olivomycin).

Authors:  W Kersten; H Kersten; W Szybalski
Journal:  Biochemistry       Date:  1966-01       Impact factor: 3.162

10.  Pharmacokinetics and systemic bioavailability of menogaril, an anthracycline antitumor agent, in the mouse, dog, and monkey.

Authors:  W J Adams; J P McGovren; E A Dalm; J E Brewer; J D Hosley
Journal:  Cancer Res       Date:  1989-11-15       Impact factor: 12.701

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.